Recent Publications by CFE Educators

Recent Published articles, books, and other scholarship by Academy members, CFE Education Scientists, and CFE Faculty.
Does Implant Removal Across the Sacroiliac Joint Improve Pain and Outcomes?
2020
Authors: Firoozabadi R, Kovalenko B, Toogood P
OBJECTIVES
To determine if removal of previously inserted iliosacral screws improved posterior pelvic pain and Short Musculoskeletal Form Assessment (SMFA) scores.
DESIGN
Retrospective database review.
SETTING
Level-1 trauma center.
PATIENTS/INTERVENTION
Twenty-five patients who underwent iliosacral screw removal.
MAIN OUTCOME MEASURE
SMFA score.
RESULTS
Eighty-eight percent of patients stated that they were satisfied with the procedure and would undergo screw removal again. SMFA functional and bothersome scores decreased (improved) after the screw removal procedure, both at 3 months and at the final follow-up. Two-eight percent of the patients required narcotics before surgery compared with 8% after screw removal. No surgical complications occurred during screw removal.
CONCLUSION
A select group of patients who have symptomatic screws across the sacroiliac joint may benefit from elective screw removal.
LEVEL OF EVIDENCE
Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
View on PubMedPubic Hair Grooming and Sexually Transmitted Infections: A Clinic-Based Cross-Sectional Survey.
2020
Authors: Gaither TW, Fergus K, Sutcliffe S, Cedars B, Enriquez A, Lee A, Mmonu N, Cohen S, Breyer B
BACKGROUND
Pubic hair grooming has been correlated with a self-reported history of sexually transmitted infections (STIs). We examined this relationship further in a cross-sectional survey of patients attending an urban STI clinic in San Francisco in 2018.
METHODS
Pubic hair grooming practices and detailed sexual histories were obtained. Sexually transmitted infections were confirmed via laboratory diagnosis or physical examination by a licensed provider.
RESULTS
A total of 314 individuals completed the survey. The median age of participants was 31 years. In total, there were 247 (80%) men, 58 (19%) women, and 5 (2%) transgender participants. Of the 247 men, 177 (72%) identified as gay or bisexual. Twenty-five (82%) of 314 patients reported pubic hair grooming within the past 3 months. Seventy-eight (25%) patients were diagnosed with a new STI during their visit. There were no significant associations between reporting any anal or genital grooming and being diagnosed with an STI. However, anal groomers were 3 times as likely to be diagnosed with a rectal STI after adjustment (adjusted odds ratio, 3.0; 95% confidence interval, 1.2-7.5) compared with genital only groomers and nongroomers. Participants who report removing all of their pubic hair more than 6 times within the past year had higher prevalence of genital STIs (33.3%, 6-10 times; 28.6%, >10 times) compared with participants who never groom all of their pubic hair (15.3%, P = 0.01).
CONCLUSIONS
We found no association between recent grooming and genital STIs. Anal grooming was associated with rectal STIs in gay and bisexual men.
View on PubMedGetting Neighborly in 2030: A Shared Fellow Workspace Improves Communication, Teaching, and Burnout.
2020
Authors: Block BL, Anderson D, O'Brien B, Babik J
Beyond High-Stakes Testing: Learner Trust, Educational Commodification, and the Loss of Medical School Professionalism.
2020
Authors: Hafferty FW, O'Brien BC, Tilburt JC
Assessment of Unused Opioids Following Ambulatory Surgery.
2020
Authors: Dixit AA, Chen CL, Inglis-Arkell C, Manuel SP
BACKGROUND
Surgery is a risk factor for opioid initiation and subsequent abuse. Discharge opioid prescription patterns after surgery are often varied and not evidence based, which may lead to unnecessary prescription of opioids. We aimed to assess opioid prescribing and unused opioid prescriptions in ambulatory surgery patients at our academic hospital.
METHODS
We conducted a retrospective observational study based on phone survey and electronic medical records. Adult patients who underwent ambulatory surgery at our large, multisite, tertiary-care hospital system were asked whether they were using the opioids that were prescribed at discharge. Our main outcomes were opioid prescription (defined as being prescribed an opioid on discharge) and unused opioid prescription (defined as being prescribed an opioid but not taking any opioids on postoperative day 1). We evaluated predictors of opioid prescription and unused opioid prescription through univariable and multivariable analyses. We also stratified outcomes by surgical service.
RESULTS
Of 4248 adult patients who underwent ambulatory surgical procedures, 3279 (77.2%) responded to the survey. Of all responders, 2146 (65.4%) were prescribed postoperative opioids, and 1240 (57.8%) reported not taking them on postoperative day 1. The highest rates of unused opioid prescriptions were for patients whose primary service were orthopedic surgery (65%) and plastic surgery (62%).
DISCUSSION
Opioid prescribing and unused opioid prescriptions are prevalent in our hospital's ambulatory surgical population. Patients undergoing selected ambulatory surgical procedures may not require as much opioid as is currently being prescribed.
View on PubMedWe Asked the Experts: How Can One Troubleshoot Loss of Intraoperative Nerve Monitoring During Head and Neck Surgery?
2020
Authors: Kim J, Roman SA
Trainee and Program Director Perspectives on Meaningful Patient Attribution and Clinical Outcomes Data.
2020
Authors: Rosenbluth G, Tong MS, Condor Montes SY, Boscardin C
Anti-gamma-aminobutyric acid receptor type A encephalitis: a review.
2020
Authors: Guo CY, Gelfand JM, Geschwind MD
PURPOSE OF REVIEW
To systematically review the clinical features, diagnosis, and management of anti-gamma-aminobutyric acid receptor Type A (GABAA) autoimmune encephalitis with a focus on recent data.
RECENT FINDINGS
In a review of published reports, we identified 50 cases of anti-GABAA receptor encephalitis with clinical features reported. The median age at presentation was 47 years old (range, 2.5 months-88 years old), 64% were adults, 36% were children and it occurred in both males and females. Eight-two percent (41/50) presented with seizures, 72% (36/50) with encephalopathy, and 58% (29/50) with both. Of those presenting with seizures, 42% developed status epilepticus during their disease course. Ninety-six percent (48/50) had MRI results reported, with 83% of these cases having abnormal findings, most commonly multifocal/diffuse cortical and subcortical T2/FLAIR hyperintense lesions without associated gadolinium enhancement. Almost one-third, 28% (14/50), had an associated malignancy detected by the time of diagnosis, 64% (9/14) of which was thymoma. Of 44 patients with outcomes reported, 80% had partial or complete recovery, whereas 20% had poor outcomes including 11% (5/44) who died. Of the 42 patients with type of treatment(s) and outcomes reported, 54% (23/42) received only first-line immunotherapy and 31% (13/42) received first-line and second-line immunotherapy. Receiving a combination of first-line and second-line immunotherapy may be associated with higher likelihood of complete recovery. When follow-up MRIs were reported, all showed improvement, and sometimes complete resolution, of T2/FLAIR hyperintensities.
SUMMARY
Anti-GABAA receptor encephalitis can present across the age spectrum and should be considered in patients who present with rapidly progressive encephalopathy and/or seizures. Brain MRI often shows a distinctive pattern of multifocal cortical and subcortical T2/FLAIR hyperintense lesions, generally not typical of other known central nervous system autoantibody associated encephalitis syndromes. High clinical suspicion and early diagnosis are important given the potential for clinical improvement with immunotherapy.
View on PubMedFrom Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality.
2020
Authors: Nachega JB, Grimwood A, Mahomed H, Fatti G, Preiser W, Kallay O, Mbala PK, Muyembe JT, Rwagasore E, Nsanzimana S, Ngamije D, Condo J, Sidat M, Noormahomed EV, Reid M, Lukeni B, Suleman F, Mteta A, Zumla A
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
2020
Authors: Meyers TJ, Weiner AB, Graff RE, Desai AS, Cooley LF, Catalona WJ, Hanauer SB, Wu JD, Schaeffer EM, Abdulkadir SA, Kundu SD, Witte JS
Inflammatory bowel disease (IBD) is an established risk factor for colorectal cancer. Recent reports suggesting IBD is also a risk factor for prostate cancer (PC) require further investigation. We studied 218 084 men in the population-based UK Biobank cohort, aged 40 to 69 at study entry between 2006 and 2010, with follow-up through mid-2015. We assessed the association between IBD and subsequent PC using multivariable Cox regression analyses, adjusting for age at assessment, ethnic group, UK region, smoking status, alcohol drinking frequency, body mass index, Townsend Deprivation Index, family history of PC and previous prostate-specific antigen testing. Mean age at study entry was 56 years, 94% of the men were white, and 1.1% (n = 2311) had a diagnosis of IBD. After a median follow-up of 78 months, men with IBD had an increased risk of PC (adjusted hazard ratio [aHR] = 1.31, 95% confidence interval [CI] = 1.03-1.67, P = .029). The association with PC was only among men with the ulcerative colitis (UC; aHR = 1.47, 95% CI = 1.11-1.95, P = .0070), and not Crohn's disease (aHR 1.06, 95% CI = 0.63-1.80, P = .82). Results are limited by lack of data on frequency of health care interactions. In a large-scale, prospective cohort study, we detected an association between IBD, and UC specifically, with incident PC diagnosis.
View on PubMed